02/20/2015 01:04 PM EST
In the first experimental use of algorithms that employ structure-based molecular modeling to optimize deimmunized drug candidates, Dartmouth researchers complement their prior sequence-based deimmunizing algorithms and expand the tool kit of protein engineering technologies to use in next generation drug development.
Source
The Geisel School of Medicine at Dartmouth
This is an NSF News From the Field item.
댓글 없음:
댓글 쓰기